Full Press Release Details
Media
• February 18, 2026
IRWD Positive Sentiment
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Investor Update Call
Key Takeaway: Ironwood Pharmaceuticals has announced it will host an investor update call for the fourth quarter and full year of 2025. This call aims to provide shareholders with insights into the company's financial performance and strategic direction. The event underscores Ironwood's commitment to maintaining open communication with its investors.
Price reaction · baseline $4.78 (2026-02-17 close) · hit after-hours · clean, no other IRWD news in the window
day 0 close
0%
Market Sentiment Analysis
POSITIVE FACTORS
- Ironwood Pharmaceuticals is engaging with investors.
- The update call provides insights into the company's performance.
- The event highlights the company's commitment to transparency.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)
Frequently Asked Questions
When is the Ironwood investor update call scheduled?
The investor update call is scheduled for February 18, 2026.
What will the investor call cover?
The call will cover Ironwood's performance for the fourth quarter and full year of 2025.
Where can I find more information about the call?
More information is available on Ironwood Pharmaceuticals' investor relations website.